Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viviane Hess

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|May 1, 2023
Changes of peripheral T cell subsets in melanoma patients with immune-related adverse eventsBenjamin Müller, Anne Bärenwaldt, Petra Herzig, et al.
BMC Cancer|October 1, 2014
Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort studyBenjamin Kasenda, Annatina Bass, Dieter Koeberle, et al.
Oncology|March 9, 2007
Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKKUte Gick, Christoph Rochlitz, Walter Mingrone, et al.
BMC Psychology|January 1, 2020
A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered bodily interventions (KPTK): study protocolAstrid Grossert, Cornelia Meffert, Viviane Hess, et al.
Frontiers in Psychology|April 24, 2023
Group-based body psychotherapy improves appreciation of body awareness in post-treatment cancer patients: A non-randomized clinical trialAstrid Grossert, Cornelia Meffert, Viviane Hess, et al.
The Lancet. Oncology|February 6, 2008
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trialViviane Hess, Bengt Glimelius, Philipp Grawe, et al.
JMIR Cancer|August 28, 2023
Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical TrialGunther Meinlschmidt, Astrid Grossert, Cornelia Meffert, et al.
Pharmacology|February 18, 2024
Hepatic Artery Infusion Chemotherapy for Primary and Secondary Malignancies of the Liver: State of the Art and Current High-Level EvidenceChristoph Kuemmerli, Viviane Hess, Philipp Dutkowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2009
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?Karin Ribi, Dieter Koeberle, Jan C Schuller, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2022
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trialCédric Panje, Stefanie Hayoz, Wolfgang Eisterer, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|May 1, 2023
Changes of peripheral T cell subsets in melanoma patients with immune-related adverse eventsBenjamin Müller, Anne Bärenwaldt, Petra Herzig, et al.
BMC Cancer|October 1, 2014
Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort studyBenjamin Kasenda, Annatina Bass, Dieter Koeberle, et al.
Oncology|March 9, 2007
Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKKUte Gick, Christoph Rochlitz, Walter Mingrone, et al.
BMC Psychology|January 1, 2020
A clinical trial of group-based body psychotherapy to improve bodily disturbances in post-treatment cancer patients in combination with randomized controlled smartphone-triggered bodily interventions (KPTK): study protocolAstrid Grossert, Cornelia Meffert, Viviane Hess, et al.
Frontiers in Psychology|April 24, 2023
Group-based body psychotherapy improves appreciation of body awareness in post-treatment cancer patients: A non-randomized clinical trialAstrid Grossert, Cornelia Meffert, Viviane Hess, et al.
The Lancet. Oncology|February 6, 2008
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trialViviane Hess, Bengt Glimelius, Philipp Grawe, et al.
JMIR Cancer|August 28, 2023
Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical TrialGunther Meinlschmidt, Astrid Grossert, Cornelia Meffert, et al.
Pharmacology|February 18, 2024
Hepatic Artery Infusion Chemotherapy for Primary and Secondary Malignancies of the Liver: State of the Art and Current High-Level EvidenceChristoph Kuemmerli, Viviane Hess, Philipp Dutkowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 10, 2009
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?Karin Ribi, Dieter Koeberle, Jan C Schuller, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2022
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trialCédric Panje, Stefanie Hayoz, Wolfgang Eisterer, et al.
Pageof 3